Syncona logo

Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by current CEO Martin Murphy and the Wellcome Trust, before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[1] Its Chair is Melanie Gee.[2]

References

  1. ↑ "BACIT Changes Name To Syncona After Investment Shift". Morning Star. 19 December 2016. Retrieved 4 March 2017.
  2. ↑ "Tigue exiting Syncona as investment banker Gee joins board". Citywire. 6 June 2019. Retrieved 5 August 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.